Fetal BloodHematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationCord Blood Stem Cell TransplantationTransplantation ConditioningGraft vs Host DiseaseTransplantation, AutologousAntigens, CD34Stem CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationBone Marrow TransplantationTransplantation ChimeraTissue DonorsTreatment OutcomeHematopoiesisHistocompatibility TestingGraft SurvivalMyeloablative AgonistsWhole-Body IrradiationHistocompatibilityHematopoietic Stem Cell MobilizationBusulfanLeukemiaGraft vs Leukemia EffectChimerismRetrospective StudiesLiver TransplantationRecurrenceCell DifferentiationBone Marrow CellsHematologic DiseasesMesenchymal Stem Cell TransplantationImmunosuppressive AgentsRemission InductionCell LineageHLA AntigensUnrelated DonorsCombined Modality TherapyHepatic Veno-Occlusive DiseaseSiblingsCell TransplantationMultiple MyelomaTime FactorsVidarabineLeukemia, Myeloid, AcuteFlow CytometryMyelodysplastic SyndromesStem Cell NicheSurvival RateEmbryonic Stem CellsDisease-Free SurvivalAdult Stem CellsGraft vs Tumor EffectTransplantation ImmunologySurvival AnalysisSevere Combined ImmunodeficiencyColony-Forming Units AssayMelphalanMice, Inbred C57BLBone MarrowKidney TransplantationLymphocyte TransfusionTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideSpinal CordGranulocyte Colony-Stimulating FactorCells, CulturedDonor SelectionSalvage TherapyCytomegalovirus InfectionsAnemia, AplasticCell SeparationAntilymphocyte SerumAllograftsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesFollow-Up StudiesMesenchymal Stromal CellsAcute DiseaseLymphocyte DepletionStem Cell FactorAntineoplastic Combined Chemotherapy ProtocolsGraft RejectionCell ProliferationMice, SCIDMultipotent Stem CellsPluripotent Stem CellsImmunosuppressionOpportunistic InfectionsImmunocompromised HostLymphoma, Non-HodgkinLymphoproliferative DisordersFetal Stem CellsOrgan TransplantationTransplantationCell Culture Techniques